Season 1

Despite interruptions due to COVID-19, Congress continues working to address health disparities, chronic disease, and relief for coronavirus. Terry interviews Congressman Fred Upton, co-author of the 21st Century Cures Act, t...

Can technology improve healthcare, even without the in-person relationship? Telemedicine has seen an explosion of utilization due to the pandemic. On this episode, we explore the countless new technologies that are changing h...

At the pharmacy counter, patients are often surprised by mysterious high costs, due to pharmaceutical benefit managers (PBMs). These middlemen lead to inconsistent and unclear prices, making it difficult for chronic disease p...

COVID-19 has hit minority populations particularly hard, delivering a wake-up call to healthcare policymakers. How can we change the system to help marginalized communities get access to the care they need? Dr. Bob speaks wit...

Patients with rare diseases may soon have better access to treatments. A second installment to the 21st Century Cures Act is in the works that would make improvements to telemedicine and digital health regulations. Find out w...

Made in the USA: The return of drug manufacturing to the U.S. could help improve drug safety, cost, and accessibility for patients with chronic disease. Dr. Janet Woodcock is director of the FDA’s Center for Drug Evaluation a...

A victory for patients in Oklahoma as the state bans a discriminatory healthcare metric. Quality-adjusted-life-years (QALYs) are used by numerous insurance companies to block coverage based on disability or age. Two mothers o...

Higher quality care at lower prices might be possible. Some companies are harnessing the power of anonymous, patient data to improve patient protocols and replace pharmacy benefit managers. Dr. Bob sits down with two leaders ...

What will this cost? It’s the big question when it comes to healthcare, and it’s often impossible to answer. Health care policy expert David Balat explains how transparent pricing models put patients in control of their healt...

The nation is focused on development of a COVID-19 vaccine. And there’s conflicting information from all sides. For those with chronic illnesses, a vaccine will be even more critical if they hope to return to offices and cli...

Health economist Dr. Paul C. Langley explains the faults in ICER’s price calculations. Dr. Bob discusses his antibody test for COVID-19, and Kate speaks with a mother whose son passed away due to insulin rationing. Guest: Pau...

Many patients with chronic illnesses have had their treatments delayed or postponed as healthcare shifts its focus to COVID-19. Lifesaving procedures for the chronically ill have been put on the back burner. How does the heal...

Restaurant menus list their prices. So why not hospitals? Unfortunately, patients usually don’t know the cost of their procedure or medication until they get the bill. Getting access to hospital pricing is also just as diffic...

COVID-19 has brought global attention to the fragility of the medical supply chain. For those with chronic illnesses, drug shortages and access to medication often are lifelong battles. As the coronavirus spread begins to slo...

Medical supply chains that transport medications for chronically ill patients are at risk of shutting down due to COVID-19. And for those that have contracted the disease, getting access to clinical trials is not an easy proc...

As coronavirus continues to spread across New York City, other virus hot spots are emerging across the country, including Detroit and New Orleans. These epicenters are seeing a surge in coronavirus patients but lack the medic...

Both the federal and state governments have begun turning to the private sector for solutions to supply tests, masks, and other necessary materials for fighting COVID-19. The private sector may also have potential coronavirus...

Fears of shortages of critical health supplies like hospital gowns, masks and drugs are a big topic on every media channel. Public health leaders are concerned about reports healthcare professionals are running short of the p...

What does coronavirus spread across the country mean for the 10 million Americans who are immuno-deficient? While COVID-19 poses a risk for the elderly, it is also concerning for Americans suffering from underlying chronic he...

Price: one the of largest barriers to medical treatment and accessible medicine. As many patients struggle to afford the high price tags at the pharmacy, there might soon be a solution. As more biosimilars enter the commercia...

The Centers for Medicare & Medicaid services are about to put a rule in place that allows insurers and pharmacy benefit managers to get paid TWICE for some of your prescriptions. This policy is called “the copay accumulator,”...